Conclusion Although genetic and epidemiological data are interesting, available evidence
supporting vitamin D supplementation in MS is still lacking. We believe that vitamin D …

D3 serum levels above 100 nmol/l on average, a concentration that can be achieved by
taking 2000–4000 IU/day of vitamin D3. These doses are considered safe and potentially …

Background Accumulating evidences from experimental, epidemiologic and clinical studies
support the potential linkage between poor vitamin D status and the risk of developing …

You recently published a letter by Dr. Fragoso and colleagues [1] that provided a short
description of 21 patients with relapsing remitting multiple sclerosis (MS) who were treated …

Hypovitaminosis D is currently one of the most studied environmental risk factors for multiple
sclerosis (MS) and is potentially the most promising in terms of new clinical implications …

Introduction Vitamin D has long been known for its immune-modulating effects, next to its
function in calcium metabolism. As a consequence, poor vitamin D status has been …

Introduction: Vitamin D has attracted a lot of attention in relation to multiple sclerosis (MS)
and many other disorders; however, the evidence for a major role (s) for vitamin D in MS is …

Background: An association between multiple sclerosis (MS) prevalence as well as MS
mortality and vitamin D nutrition has led to the hypothesis that high levels of vitamin D could …

Low serum levels of 25-hydroxyvitamin D [25 (OH) D] and low sunlight exposure are known
risk factors for the development of multiple sclerosis. Add-on vitamin D supplementation …

It is difficult to be the devil's advocate, the role of Caroline Papeix and Catherine Lubetzki,
since the evidence, admittedly circumstantial and inferential, suggests that a) vitamin D in …